NOVO NORDISK A/S |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 132.9 USD | +0.77% |
|
+0.38% | +28.48% |
| 05-20 | US Equity Markets Close Mixed Monday After Fed Officials' Remarks | MT |
| 05-20 | Novo Nordisk's Wegovy May Be More Effective for Patients With Specific Genes, Study Shows | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 693B | ||||||
| 372B | ||||||
| 332B | ||||||
| 294B | ||||||
| 239B |
